Showing results (71-80 of 206) with videos related to

Sort By:
Pageof 21
The Journal of Urology|October 20, 2020
Comparative Effectiveness of Immune Checkpoint Inhibitors in Patients with Platinum Refractory Advanced Urothelial CarcinomaUmang Swami, Benjamin Haaland, Adam Kessel, et al.
Future Oncology (London, England)|July 29, 2024
Treatment patterns and outcomes in patients with nonmetastatic castration-resistant prostate cancer in the United StatesUmang Swami, Agnes Hong, Brandon Diessner, et al.
Head & Neck|December 12, 2018
Cutaneous malignant melanoma of the oral cavity following skin graft reconstruction: Case reportZachary Mayo, Steven Seyedin, Michael Marquardt, et al.
Cancer Chemotherapy and Pharmacology|July 27, 2014
Treatment of resistant metastatic melanoma using sequential epigenetic therapy (decitabine and panobinostat) combined with chemotherapy (temozolomide)Chang Xia, Roberto Leon-Ferre, Douglas Laux, et al.
Annals of Translational Medicine|July 19, 2021
Safety of immune checkpoint inhibitors in patients with cancer and pre-existing autoimmune diseaseSwetha Alexander, Umang Swami, Aneet Kaur, et al.
Gynecologic Oncology|July 24, 2013
Clinical outcome and prognostic markers for patients with gynecologic malignancies in phase 1 clinical trials: a single institution experience from 1999 to 2010June Y Hou, Santiago Aparo, Mohammad Ghalib, et al.
European Journal of Cancer Care|December 5, 2018
Discrepancy between treatment goals documentation by oncologists and their understanding among cancer patients under active treatment with chemotherapyVarun Monga, Seth M Maliske, Hassan Kaleem, et al.
The Journal of Urology|February 15, 2023
The Role of Physician Specialty in the Underutilization of Standard-of-Care Treatment Intensification in Patients With Metastatic Castration-sensitive Prostate CancerUmang Swami, Agnes Hong, Nader N El-Chaar, et al.
International Journal of Radiation Oncology, Biology, Physics|February 8, 2025
A Phase 2 Trial of Radium223 and Stereotactic Ablative Radiation Therapy in Hormone-Naïve Men with Oligometastatic Prostate Cancer to Bone: The RadSABR StudyJonathan Tward, Shane Lloyd, Skyler Johnson, et al.
The Oncologist|March 7, 2024
A Phase II Study of Rucaparib Monotherapy in Nonmetastatic, Hormone-Sensitive Prostate Cancer Demonstrating "BRCAness" Genotype (ROAR)Kamal Kant Sahu, Haoran Li, Vinay Mathew Thomas, et al.
Pageof 21